Ratings by Jones Trading (Soumit Roy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/25/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2024 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
52.65 (47.10) |
-10.54% | Details | |
| 4/11/2024 | Monopar Therapeutics | MNPR | Upgrade | Buy (Hold) |
0.64 (0.63) |
-1.56% | Details | |
| 3/27/2024 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.27 (1.04) |
-18.11% | Details | |
| 3/7/2024 | Adaptimmune Therapeutics plc | ADAP | Upgrade | Buy (Hold) |
1.71 (1.06) |
-38.01% | Details | |
| 2/13/2024 | Adicet Bio Inc. | ACET | Upgrade | Buy (Hold) |
3.12 (1.81) |
-41.99% | Details | |
| 10/30/2023 | Deciphera | DCPH | Upgrade | Buy (Hold) |
10.15 (14.18) |
39.7% | Details | |
| 10/9/2023 | Mirati Therapeutics | MRTX | Downgrade | Hold (Buy) |
62.38 (58.70) |
-5.9% | Details | |
| 10/5/2023 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
8.12 (19.25) |
137.07% | Details | |
| 8/18/2023 | Tracon Pharmaceuticals | TCON | Downgrade | Hold (Buy) |
0.20 (1.79) |
795% | Details | |
| 8/18/2023 | Acrivon Therapeutics Inc | ACRV | New Coverage | Buy (N/A) |
11.26 (8.47) |
-24.78% | Details | |
| 8/10/2023 | Monopar Therapeutics | MNPR | Downgrade | Hold (Buy) |
0.73 (0.63) |
-13.7% | Details | |
| 5/24/2023 | Oncolytics Biotech | ONCY | New Coverage | Buy (N/A) |
1.91 (1.08) |
-43.46% | Details | |
| 5/22/2023 | Rain Therapeutics | RAIN | Downgrade | Hold (Buy) |
9.93 (1.21) |
-87.81% | Details | |
| 4/12/2023 | Aeglea Biotherapeutics | AGLE | Downgrade | Hold (Buy) |
0.26 (12.01) |
4519.23% | Details | |
| 3/6/2023 | Adaptimmune Therapeutics plc | ADAP | Downgrade | Hold (Buy) |
1.76 (1.06) |
-39.77% | Details | |
| 1/6/2023 | Deciphera | DCPH | Upgrade | Hold (Sell) |
19.76 (14.18) |
-28.24% | Details | |
| 12/13/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2022 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Inhibikase Therapeutics Inc | IKT | Downgrade | Hold (Buy) |
0.54 (1.90) |
251.85% | Details | |
| 11/8/2022 | HCW Biologics Inc. | HCWB | New Coverage | Buy (N/A) |
2.25 (1.46) |
-35.11% | Details | |
| 10/31/2022 | AVEO Pharmaceuticals | AVEO | Downgrade | Hold (Buy) |
14.77 (15.00) |
1.56% | Details | |
| 9/6/2022 | Day One Biopharmaceuticals | DAWN | New Coverage | Buy (N/A) |
23.76 (13.21) |
-44.4% | Details | |
| 8/12/2022 | Infinity Pharmaceutical | INFI | Downgrade | Hold (Buy) |
1.08 (0.04) |
-96.3% | Details | |
| 8/1/2022 | Aileron Therapeutics Inc | ALRN | Downgrade | Hold (Buy) |
0.19 (5.00) |
2531.58% | Details | |
| 7/20/2022 | Vascular Biogenics Ltd | VBLT | Downgrade | Hold (Buy) |
2.05 (0.16) |
-92.2% | Details | |
| 6/30/2022 | Aileron Therapeutics Inc | ALRN | Downgrade | Hold (Buy) |
0.41 (5.00) |
1119.51% | Details | |
| 6/23/2022 | Rain Therapeutics | RAIN | New Coverage | Buy (N/A) |
2.36 (1.21) |
-48.73% | Details | |
| 5/10/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2022 | Silverback Therapeutics | SBTX | Downgrade | Hold (Buy) |
3.51 (5.87) |
67.24% | Details | |
| 3/14/2022 | AVEO Pharmaceuticals | AVEO | New Coverage | Buy (N/A) |
3.78 (15.00) |
296.83% | Details | |
| 3/26/2021 | Celyad SA | CYAD | Downgrade | Hold (Buy) |
7.61 (0.47) |
-93.82% | Details | |
| 3/17/2021 | Cassava Sciences | SAVA | New Coverage | Buy (N/A) |
52.16 (21.73) |
-58.34% | Details | |
| 2/22/2021 | Aptose Biosciences | APTO | New Coverage | Buy (N/A) |
4.31 (1.16) |
-73.09% | Details | |
| 7/2/2020 | T2 Biosystems, Inc | TTOO | Maintain | Buy (N/A) |
|
Details | ||
| 6/19/2020 | Trillium Therapeutics | TRIL | New Coverage | Buy (N/A) |
8.23 (18.44) |
124.06% | Details | |
| 5/29/2020 | Adaptimmune Therapeutics plc | ADAP | Upgrade | Buy (Hold) |
4.86 (1.06) |
-78.19% | Details | |
| 4/29/2020 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | Forty Seven Inc. | FTSV | Downgrade | Hold (Buy) |
93.91 (95.51) |
1.7% | Details | |
| 8/1/2019 | T2 Biosystems, Inc | TTOO | Downgrade | Hold (Buy) |
1.44 (2.74) |
90.28% | Details |
